February 25, 2026 – SEATTLE, Wash. – Over the past two decades, advancements in medical care have extended the health span of Americans by 1.3 years, a new study reveals. However, these improvements have come with a significant increase in medical spending, amounting to $234,000 per person over their lifetime, or approximately $182,000 for each additional year of healthy life gained when measured from birth. These findings are detailed in a comprehensive national study published today in Value in Health.
Researchers from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine conducted an extensive assessment of health-adjusted life expectancy (HALE) and lifetime healthcare spending. By evaluating changes in 132 causes of disease across all age groups between 1996 and 2016, the study offers the most thorough examination to date of what Americans have received in return for rising medical costs.
Understanding the Distribution of Healthcare Spending
According to senior author Marcia Weaver, PhD, the study highlights the importance of not just how much the nation spends on healthcare, but where those dollars are allocated and what they achieve. “These findings highlight that the problem is not simply how much the nation spends on healthcare, but where those dollars go and what they achieve,” she stated.
Approximately 60% of the conditions studied, including ischemic heart disease, stroke, and HIV/AIDS, saw substantial health gains at relatively modest costs. For instance, advancements in medications, devices, and emergency care for ischemic heart disease contributed to an additional quarter of a healthy year on average for all Americans, costing about $63,000 per healthy year gained. HIV/AIDS treatments were particularly cost-effective, producing significant increases in survival and quality of life at a low expenditure of $9,300 per healthy year gained.
Cost-Effective Health Improvements and Challenges
The study found the most favorable outcomes when HALE increased while lifetime spending decreased, a scenario true for 19 causes (14%), including breast cancer. These advances in screening and treatment reflect a shift toward less invasive and more effective care, ultimately increasing health spans while reducing costs.
Conversely, for seven causes (5%) such as alcohol use disorders, both HALE and lifetime spending decreased. For 26 causes (20%), including chronic kidney disease and drug use disorders, HALE decreased even as lifetime spending rose. Drug use disorders, in particular, significantly detracted from the overall value of U.S. healthcare during the study period.
“Disease-level spending estimates provide a foundation for identifying patterns in healthcare spending and understanding how those patterns relate to health outcomes,” noted co-author Abe Dunn, PhD, Assistant Chief Economist at the United States Bureau of Economic Analysis.
Long-Term Investments and Future Directions
The study also highlights the importance of early investments in healthcare, which often yield benefits years or decades later. When researchers recalculated the value of healthcare starting at age 65, the cost per healthy year gained dropped to about $92,000, nearly half the estimate of $182,000 when calculated from birth. This underscores the potential payoff of early prevention and treatment, especially for chronic diseases like diabetes and heart disease.
The findings suggest that efforts to control healthcare costs should focus less on across-the-board spending cuts and more on improving access to care for conditions and interventions that deliver meaningful health improvements. There is a need for continued research and innovation, particularly for conditions that incur high costs without corresponding health benefits.
“Better alignment of spending with health outcomes could significantly improve the overall value of U.S. healthcare, ultimately saving lives, improving quality of life, and making more effective use of limited resources,” emphasized Prof. Weaver.
As the nation grapples with the dual challenges of rising healthcare costs and the need for effective health interventions, this study provides a crucial roadmap for policymakers and healthcare providers aiming to optimize resource allocation and improve health outcomes for all Americans.
